{
    "nctId": "NCT02505698",
    "briefTitle": "A Data Collection Study for the Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment",
    "officialTitle": "A Data Collection Study for the Evaluation of Real Imaging's Real Imager 8 (RI-8) Developed for Risk Assessment of Breast Cancer",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Sufficient number of cancer case and controls have been imaged",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Woman has read, understood and signed the inform consent form\n* Age: 30 years and older\n* Women who are asymptomatic and are scheduled to undergo routine Mx and/or US screening OR Women summoned for breast biopsy following a suspicious finding in recent screening exam and was graded 4/5/6 on BI-RADS scale\n\nExclusion Criteria:\n\n* Women who have had a Mx (mammography) and/or US and/or MRI examination performed on the day of the study prior to MIRA scan\n* Women who had a lumpectomy surgery preceding the study\n* Women who had undergone mastectomy and/or breast reconstruction\n* Women who have undergone any type of breast surgery preceding the study\n* Women who have had a breast biopsy performed throughout the 10 weeks preceding the study\n* Women who have a fever on the day of the MIRA imaging\n* Women who are pregnant\n* Women who are breast-feeding\n* Women with implanted pacemaker/defibrillator, implanted venous access device (portacath) or other implanted devices in the chest area\n* Women who are unable to read, understand and execute written informed consent\n* Women who are have had chemotherapy and/or radiotherapy throughout the 6 months preceding the study",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}